Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetraspanin-2 protein (Sm-TSP-2) is an integral membrane protein found on the tegument (outer surface membrane) of the parasite Schistosoma mansoni, which causes schistosomiasis in humans[1][2][3]. Sm-TSP-2 is a member of the tetraspanin protein family, involved in organizing membrane microdomains (TEMs) by acting as scaffolds for multi-protein complexes that maintain membrane integrity and facilitate immune evasion[1][2]. Due to its surface exposure and essential function in parasite survival, Sm-TSP-2 is considered one of the best candidate antigens for vaccine development against schistosomiasis, having shown promise in experimental models[2][3]. It does not have known direct small molecule drugs but is being researched extensively as a vaccine component and potential antibody target[1][2].
Vaccine-induced immune targeting (immune response against the parasite surface antigen) Disruption of tegumental protein complexes (proposed therapeutic mechanism)[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetraspanin-2 protein, Schistosoma mansoni (Sm-TSP-2).